Johnson & Johnson said it will contribute up to an additional $1 billion for a potential settlement agreement to resolve US opioid lawsuits …
Johnson & Johnson (JNJ) has halted its late-stage Covid-19 vaccine trial after a study participant fell ill, news provider STAT has reported. The …
Johnson & Johnson said Monday that its Tremfya drug induced clinical and endoscopic improvements in adult patients with moderately to severely active Crohn’s …
Johnson & Johnson said that Phase1/2 trial data showed that a single dose of its COVID-19 vaccine candidate, JNJ-78436735, induced a “strong” neutralizing …
Johnson & Johnson shares are up 2.3% in Wednesday’s pre-market trading after the healthcare company announced that it is kicking off with a …
Johnson & Johnson will kick off Phase 2 trials of its COVID-19 vaccine candidate in Spain on Monday, according to the trial’s unit …
Johnson & Johnson announced Tuesday that the European Commission (EC) has approved an extended use of imbruvica (ibrutinib) in combination with rituximab for …
Johnson & Johnson and Pfizer have been in the news for the development of potential vaccines for COVID-19. According to the latest update, …
Johnson & Johnson (JNJ) is aiming to test its coronavirus vaccine in up to 60,000 volunteers in a Phase 3 clinical trial set …
The U.S.
